{"id":"CHEMBL10413","canonicalSmiles":"O=C(O)Cn1c(=O)n(Cc2ccc(Br)cc2F)c(=O)c2ccc(Cl)cc21","inchiKey":"SXONDGSPUVNZLO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZENARESTAT","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CI-1014","FK-366","FR-74366","Zenarestat"],"crossReferences":{"PubChem":["144210777","170466650"],"drugbank":["DB02132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1067","canonicalSmiles":"NC(=O)N1c2ccccc2CC(O)c2ccccc21","inchiKey":"BMPDWHIDQYTSHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LICARBAZEPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["10-hydroxy-carbamazepine","Licarbazepine"],"crossReferences":{"Wikipedia":["Eslicarbazepine_acetate","Licarbazepine"],"chEBI":["701"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1075733","canonicalSmiles":"CCC(C)C(CC)C(N)=O","inchiKey":"QRCJOCOSPZMDJY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALNOCTAMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Axiquel"],"synonyms":["MCN-X-181","NSC-32363","NSC-34092","Valnoctamide"],"crossReferences":{"Wikipedia":["Valnoctamide"],"drugbank":["DB13099"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1079087","canonicalSmiles":"COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\\C[C@@H](C)OC2=O","inchiKey":"NEQZWEXWOFPKOT-QHSZRYGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1079087","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07788"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1131","canonicalSmiles":"COc1cc(C)c(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)c(C)c1C","inchiKey":"IHUNBGSDBOWDMA-AQFIFDHZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ACITRETIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acitretin","Neotigason","Soriatane"],"synonyms":["Acitretin","Etretin","RO 10-1670","RO 10-1670/000","RO-101670000"],"crossReferences":{"DailyMed":["acitretin"],"PubChem":["144205565","26756475","29216416","49640651"],"Wikipedia":["Acitretin"],"drugbank":["DB00459"],"chEBI":["50173"]},"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819","ENSG00000204231","ENSG00000143171","ENSG00000186350"],"count":6},"linkedDiseases":{"rows":["EFO_1001494","EFO_0000756","EFO_0000764","MONDO_0004975","EFO_0000701","EFO_0000676","MONDO_0002406","EFO_0000707"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for psoriasis and psoriasis vulgaris and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL118","canonicalSmiles":"Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1","inchiKey":"RZEKVGVHFLEQIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CELECOXIB","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"],"year":2011},"tradeNames":["Celebra","Celebrex","Celecoxib","Elyxyb","Onsenal"],"synonyms":["Celecoxib","DFN-15","DFN15","NSC-719627","NSC-758624","SC-58635"],"crossReferences":{"DailyMed":["celecoxib"],"PubChem":["144204686","144209162","144210916","170464693","17389545","26747363","49665790","49666478","535138"],"Wikipedia":["Celecoxib"],"drugbank":["DB00482"],"chEBI":["41423"]},"childChemblIds":["CHEMBL395268","CHEMBL1801594"],"linkedTargets":{"rows":["ENSG00000073756"],"count":1},"linkedDiseases":{"rows":["EFO_0000365","EFO_0000756","EFO_0000681","EFO_0003768","EFO_1001951","MONDO_0002974","EFO_0009582","MONDO_0008903","EFO_0004616","EFO_0001668","MONDO_0004976","EFO_1001904","EFO_0004288","MONDO_0002715","EFO_0005762","EFO_0002618","HP_0012532","EFO_0010072","MONDO_0002363","MONDO_0042487","Orphanet_636","EFO_0004607","EFO_0000384","MONDO_0008315","EFO_0002496","MONDO_0002691","MP_0001914","EFO_0009260","EFO_0000546","EFO_0007328","HP_0100607","EFO_0001378","MONDO_0002258","EFO_0003767","MONDO_0018373","MONDO_0007254","EFO_0000284","EFO_0004252","MONDO_0044937","EFO_0009606","EFO_0000289","MONDO_0002050","EFO_0000326","EFO_1001893","MONDO_0002618","EFO_0009625","EFO_0000616","EFO_0006859","EFO_0001645","EFO_0003898","HP_0011110","MONDO_0007576","HP_0003418","EFO_0001073","EFO_0003843","EFO_0000537","EFO_0000199","MONDO_0024880","MONDO_0005178","EFO_0000519","MONDO_0024475","EFO_0008525","EFO_0003869","EFO_0005543","EFO_0001075","MONDO_0002009","Orphanet_905","EFO_0005406","EFO_0004274","EFO_1000657","EFO_0004251","Orphanet_733","EFO_1000786","EFO_0000182","EFO_1001228","HP_0003419","EFO_1000166","EFO_1001250","EFO_0001416","EFO_0003893","MONDO_0004658","EFO_0004224","MONDO_0008170","EFO_1001466","EFO_0002939","Orphanet_3389","EFO_1002029","EFO_0004239","MP_0001845","MONDO_0100096","MONDO_0003937","EFO_0000731","EFO_0003868","EFO_0000668","MONDO_0021640","MONDO_0005090","EFO_0007453","EFO_0005252","MONDO_0021063","MONDO_0002087","Orphanet_538","EFO_0000305","MONDO_0001187","HP_0004398","MONDO_0005277","EFO_1001480","MONDO_0004247","EFO_0000712","MONDO_0001657","EFO_0000673","EFO_0005279","EFO_0004242","EFO_0007490","EFO_1000158","EFO_0000685","EFO_0003060","EFO_0000621","EFO_0002609","EFO_0000311","EFO_0005755","EFO_0000203","EFO_0001072","MONDO_0004975","EFO_0004142","EFO_0000706","EFO_0005611","EFO_1001950","EFO_0000691"],"count":128},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 17 approved and 92 investigational indications. It was withdrawn in European Union  in 2011. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200446","canonicalSmiles":"CN(C)CCN(Cc1ccccc1)c1ccccn1.Cl","inchiKey":"FSSICIQKZGUEAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPELENNAMINE HYDROCHLORIDE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1241","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pbz-sr","Tripelennamine hydrochloride"],"synonyms":["Azaron","Dehistin","NSC-409943","Pyribenzamine","Tripelennamine chloride","Tripelennamine hcl","Tripelennamine hydrochloride","Vetibenzamina"],"crossReferences":{"PubChem":["26719674","56424144","855583"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1948."}
{"id":"CHEMBL1200461","canonicalSmiles":"COc1ccc(OC)c(C(O)CNC(=O)CN)c1.Cl","inchiKey":"MGCQZNBCJBRZDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIDODRINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201212","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bramox","Gutron","Midodrine hydrochloride","Midon","Orvaten","Proamatine"],"synonyms":["A-4020 LINZ","Amatine","Hipertan","Metligine","Midodrine hcl","Midodrine hydrochloride","Midodrine monohydrochloride","NSC-758429","ST 1085 HYDROCHLORIDE","ST 1085 [AS THE BASE]","ST-1085","ST-1085 BASE","ST-1085 HYDROCHLORIDE","ST-PETER-224","ST. PETER 224","ST1085 HYDROCHLORIDE"],"crossReferences":{"DailyMed":["midodrine%20hydrochloride"],"PubChem":["144204080","144213040","170464672","56320803"],"chEBI":["31847"]},"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["HP_0100806","EFO_0006834","EFO_0000712","EFO_0005252","EFO_1001488"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200580","canonicalSmiles":"O=S([O-])CNc1ccc(S(=O)(=O)c2ccc(NCS(=O)[O-])cc2)cc1.[Na+].[Na+]","inchiKey":"AZBNFLZFSZDPQF-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFOXONE SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1570","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Diasone sodium"],"synonyms":["Aldesulfone sodium","Aldesulphone sodium","NSC-27222","Sulfoxone sodium"],"crossReferences":{"Wikipedia":["Aldesulfone_sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for leprosy."}
{"id":"CHEMBL1200635","canonicalSmiles":"CCN(CC)CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C.Cl","inchiKey":"AKQNAIYKSALPKV-OYHXESGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTAMATE HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201263","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Magnacort"],"synonyms":["Hydrocortamate chloride","Hydrocortamate hcl","Hydrocortamate hydrochloride","NSC-12884"],"crossReferences":{"chEBI":["50854"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1200728","canonicalSmiles":"Cl.N=C(N)N","inchiKey":"PJJJBBJSCAKJQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANIDINE HYDROCHLORIDE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL821","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Guanidine hydrochloride"],"synonyms":["Guanidine HCl","Guanidine hydrochloride"],"crossReferences":{"chEBI":["32735"]},"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000168263","ENSG00000053918","ENSG00000129159","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000168418","ENSG00000135519","ENSG00000158445","ENSG00000089558","ENSG00000177301","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000184611","ENSG00000171385"],"count":40},"linkedDiseases":{"rows":["HP_0001324","EFO_0008524","EFO_0004991"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1939 and has 3 approved indications."}
{"id":"CHEMBL1200732","canonicalSmiles":"CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C","inchiKey":"ILKJAFIWWBXGDU-MOGDOJJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMCINONIDE","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amcinonide","Cyclocort"],"synonyms":["Amcinonide","CL 34699","CL-34699","NSC-758620"],"crossReferences":{"DailyMed":["amcinonide"],"PubChem":["144204964","56423154","855515"],"Wikipedia":["Amcinonide"],"drugbank":["DB00288"],"chEBI":["31199"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL1201049","canonicalSmiles":"Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1.O=[N+]([O-])O","inchiKey":"DDXORDQKGIZAME-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECONAZOLE NITRATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL808","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Econazole nitrate","Ecostatin","Ecostatin twin pack","Ecostatin-1","Ecoza","Gyno-pevaryl","Gyno-pevaryl 1 cp pack","Gyno-pevaryl 150","Gyno-pevaryl once","Pevaryl","Spectazole"],"synonyms":["Econazole nitrate","NSC-243115","R 14,827","R-14827","R14827","SQ 13050","SQ-13050","SQ13050"],"crossReferences":{"DailyMed":["econazole%20nitrate"],"PubChem":["144204403","144207969","144213703","170465422","17389020","26748545","56422230","568319","855519"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for tinea pedis."}
{"id":"CHEMBL1201216","canonicalSmiles":"Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1","inchiKey":"RFWZESUMWJKKRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPIPRAZOLE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dapiprazole"],"crossReferences":{"Wikipedia":["Dapiprazole"],"drugbank":["DB00298"],"chEBI":["51066"]},"childChemblIds":["CHEMBL1201044"],"linkedTargets":{"rows":["ENSG00000120907"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_0000516","HP_0011499"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1990 and has 3 approved indications."}
{"id":"CHEMBL1201447","drugType":"Unknown","blackBoxWarning":false,"name":"CALFACTANT","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Infasurf","Infasurf preservative free"],"synonyms":["Aerofact","Calfactant","SF-RI 1"],"crossReferences":{"DrugCentral":["4884"],"Wikipedia":["Calfactant"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL1201563","drugType":"Protein","blackBoxWarning":false,"name":"INTERFERON BETA-1B","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaseron","Extavia"],"synonyms":["BAY 86-5046","BAY-86-5046","Interferon beta-1b"],"crossReferences":{"DailyMed":["interferon%20beta-1b"],"DrugCentral":["5140"],"Wikipedia":["Interferon_beta-1b"]},"linkedTargets":{"rows":["ENSG00000159110","ENSG00000142166"],"count":2},"linkedDiseases":{"rows":["MONDO_0100116","MONDO_0100096","MONDO_0005301","EFO_0000318","EFO_0000764","EFO_0003929"],"count":6},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for multiple sclerosis and has 5 investigational indications."}
{"id":"CHEMBL1201611","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN LISPRO PROTAMINE RECOMBINANT","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Insulin lispro protamine recombinant"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148","EFO_0000400"],"count":2},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 2 investigational indications."}
{"id":"CHEMBL1201834","drugType":"Antibody","blackBoxWarning":false,"name":"CANAKINUMAB","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ilaris"],"synonyms":["ACZ-885","ACZ885","Canakinumab"],"crossReferences":{"DailyMed":["canakinumab"],"DrugCentral":["4952"],"Wikipedia":["Canakinumab"]},"linkedTargets":{"rows":["ENSG00000125538"],"count":1},"linkedDiseases":{"rows":["EFO_0004214","EFO_0001365","EFO_0000275","EFO_0003780","Orphanet_232","EFO_0004274","EFO_0000681","DOID_13406","Orphanet_575","EFO_0003778","EFO_0000756","MONDO_0007254","EFO_0001071","EFO_1001165","EFO_1001345","EFO_0009322","EFO_0000540","EFO_0004246","EFO_0003914","EFO_0008518","Orphanet_1451","EFO_0005531","Orphanet_309025","EFO_0007135","EFO_1001478","HP_0000999","EFO_0000400","Orphanet_342","EFO_0000198","EFO_0000685","EFO_1000906","HP_0001945","EFO_0003060","EFO_0002609","EFO_0003106","MONDO_0100096","EFO_1001999","MONDO_0005147","EFO_0002517","Orphanet_208650","EFO_0000341","MONDO_0005148","MONDO_0005178","EFO_0004265"],"count":44},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 7 approved and 32 investigational indications."}
{"id":"CHEMBL1221702","canonicalSmiles":"C[C@H]1CN=C(N)c2sccc2O1","inchiKey":"TUOXPJFCQDMQOX-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221702","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232258","canonicalSmiles":"CC(C)C[C@@H](N)C(=O)O","inchiKey":"ROHFNLRQFUQHCH-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-LEUCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205602","170465492","26756690"],"drugbank":["DB01746"],"chEBI":["28225"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232511","canonicalSmiles":"CCOC(=O)NC","inchiKey":"SURZCVYFPAXNGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232511","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["74451"],"drugbank":["DB02856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235440","canonicalSmiles":"O=C(O)[C@@H]1CSCN1","inchiKey":"DZLNHFMRPBPULJ-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIOPROLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Thiaproline"],"crossReferences":{"PubChem":["144205863","170466577","29217845"],"drugbank":["DB02846"],"chEBI":["45171"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL126648","canonicalSmiles":"C#CCN(Cc1cc2c(O)nc(C)nc2cc1C)c1ccc(C(=O)N[C@@H](CCc2nnn[nH]2)C(=O)O)c(F)c1","inchiKey":"IEJSCSAMMLUINT-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PLEVITREXED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bgc-9331","NSC-696259","Plevitrexed","ZD-9331","ZD9331"],"crossReferences":{"drugbank":["DB06163"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1269597","canonicalSmiles":"C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](SCCN(C)C)C(=O)N(C)[C@@H](CC(C)(C)O)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C","inchiKey":"AQHMBDAHQGYLIU-XNFHFXFQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SCY 635","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCY-635","Scy 635"],"crossReferences":{"drugbank":["DB12451"]},"linkedTargets":{"rows":["ENSG00000196262"],"count":1},"linkedDiseases":{"rows":["EFO_0004220","EFO_0003047"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1330792","canonicalSmiles":"CC(=O)Nc1cc([As](=O)(O)O)ccc1O","inchiKey":"ODFJOVXVLFUVNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETARSONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gynoplix","S.v.c.","Stovarsol"],"synonyms":["Acetarsol","Acetarsone","NSC-13160"],"crossReferences":{"PubChem":["144204889","170466503","26665850","26748312","56424027","69767","8139955"],"Wikipedia":["Acetarsol"],"drugbank":["DB13268"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for leishmaniasis and trypanosomiasis."}
{"id":"CHEMBL1367605","canonicalSmiles":"CC(NCCc1ccc(O)cc1)C(O)c1ccc(O)cc1.Cl","inchiKey":"IDLSITKDRVDKRV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITODRINE HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL83063","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ritodrine hydrochloride","Yutopar"],"synonyms":["Luteonin","NSC-291565","Ritodrine hcl","Ritodrine hydrochloride"],"crossReferences":{"PubChem":["26748517","856010"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL1374379","canonicalSmiles":"CCCCNc1ccc(C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC)cc1","inchiKey":"MAFMQEKGGFWBAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENZONATATE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benzonatate","Tessalon"],"synonyms":["Benzonatate","NSC-760128"],"crossReferences":{"DailyMed":["benzonatate"],"DrugCentral":["326"],"PubChem":["11112254","144203949","170465391","56463355"],"drugbank":["DB00868"],"chEBI":["3032"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958 and is indicated for cough. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1436","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(N)=O)CS[C@H]12)c1ccco1","inchiKey":"JFPVXVDWJQMJEE-IZRZKJBUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFUROXIME","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["640/359","Cefuroxime","Cefuroxime acid","Cefuroximine","Kefurox","Zinacef"],"crossReferences":{"DailyMed":["cefuroxime","cefuroxime%20sodium"],"drugbank":["DB01112"],"chEBI":["3515"]},"childChemblIds":["CHEMBL2146124"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 3 approved and 4 investigational indications."}
{"id":"CHEMBL1590","canonicalSmiles":"CN[C@@H](C)[C@@H](O)c1ccccc1","inchiKey":"KWGRBVOPPLSCSI-WCBMZHEXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PSEUDOEPHEDRINE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acunaso","Isoephedrine, d-","Neodurasina","Pseudoephedrine","Pseudoephedrine polistirex"],"crossReferences":{"DailyMed":["pseudoephedrine%20hydrochloride","pseudoephedrine%20sulfate"],"PubChem":["11111142"],"Wikipedia":["Pseudoephedrine"],"drugbank":["DB00852"],"chEBI":["51209"]},"childChemblIds":["CHEMBL1200724","CHEMBL1201483","CHEMBL3989855"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0008521","EFO_0007486","HP_0012735","MONDO_0024290","EFO_0005252","EFO_0007533","MONDO_0005271","MONDO_0024352","HP_0001742","EFO_0003843","EFO_0007214","MONDO_0024355","EFO_1001050","MONDO_0005277","MP_0001845","EFO_0000544","EFO_0007328","MONDO_0003276","EFO_1001417","EFO_0003956"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 10 approved and 13 investigational indications."}
{"id":"CHEMBL1592101","drugType":"Small molecule","blackBoxWarning":false,"name":"BISMUTH SUBGALLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Basic bismuth gallate","Bismuth subgallate","Gallic acid bismuth basic salt"],"crossReferences":{"PubChem":["144205941","29218038"],"chEBI":["31292"]},"linkedTargets":{"rows":["ENSG00000131187"],"count":1},"linkedDiseases":{"rows":["EFO_0009669"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for flatulence."}
{"id":"CHEMBL1597075","canonicalSmiles":"CC1CCC(C(C)C)C(OC(=O)c2ccccc2N)C1","inchiKey":"SOXAGEOHPCXXIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERADIMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Menthyl anthranilate","Meradimate"],"crossReferences":{"PubChem":["144205155","144207759","29215280"],"drugbank":["DB11096"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1605650","canonicalSmiles":"C[C@H]1CCC[C@@H](C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1","inchiKey":"LBXHRAWDUMTPSE-AOOOYVTPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1605650","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11112432","855740"],"drugbank":["DB13792"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1657","canonicalSmiles":"CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1","inchiKey":"OGQICQVSFDPSEI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAZAROTENE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arazlo","Avage","Fabior","Tazorac","Zorac"],"synonyms":["AGN 190168","AGN-190168","Idp-123","Tazarotene"],"crossReferences":{"DailyMed":["tazarotene"],"PubChem":["144206075","170464671","174006350","50112778"],"Wikipedia":["Tazarotene"],"drugbank":["DB00799"],"chEBI":["32184"]},"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819"],"count":3},"linkedDiseases":{"rows":["Orphanet_183469","MONDO_0021058","EFO_1001494","EFO_0009259","EFO_0002913","MONDO_0021582","EFO_0000701","EFO_0000676","EFO_0003894"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 5 approved and 3 investigational indications."}
{"id":"CHEMBL1658","canonicalSmiles":"C=C[C@]1(C)C[C@@H](OC(=O)CS[C@H]2C[C@@H]3CC[C@H](C2)N3C)[C@]2(C)[C@H](C)CC[C@]3(CCC(=O)[C@H]32)[C@@H](C)[C@@H]1O","inchiKey":"STZYTFJPGGDRJD-NHUWBDDWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RETAPAMULIN","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aitabax","Altabax","Altargo"],"synonyms":["NSC-759885","Retapamulin","SB-275833","Sb 275833"],"crossReferences":{"DailyMed":["retapamulin"],"drugbank":["DB01256"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for impetigo and has 2 investigational indications."}
{"id":"CHEMBL1743069","drugType":"Antibody","blackBoxWarning":false,"name":"SIFALIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MDX-1103","MEDI-545","Sifalimumab"],"linkedTargets":{"rows":["ENSG00000228083","ENSG00000233816","ENSG00000197919","ENSG00000137080","ENSG00000214042","ENSG00000120242","ENSG00000186803","ENSG00000234829","ENSG00000236637","ENSG00000120235","ENSG00000188379","ENSG00000147873","ENSG00000147885"],"count":13},"linkedDiseases":{"rows":["EFO_0002690","EFO_0000398","MONDO_0004670","EFO_0000676"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1743087","drugType":"Antibody","blackBoxWarning":false,"name":"VEDOLIZUMAB","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Entyvio"],"synonyms":["LDP-02","LDP02","MLN-0002","MLN-02","MLN0002","MLN02","Vedolizumab"],"crossReferences":{"DailyMed":["vedolizumab"],"DrugCentral":["4982"]},"linkedTargets":{"rows":["ENSG00000115232","ENSG00000139626"],"count":2},"linkedDiseases":{"rows":["EFO_0001060","EFO_0000729","MONDO_0013730","EFO_0000544","EFO_0000756","EFO_0000764","EFO_0000180","MONDO_0005147","EFO_0000540","EFO_0000384","EFO_0003921","EFO_0003767","EFO_0003872"],"count":13},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved and 7 investigational indications."}
{"id":"CHEMBL1788396","canonicalSmiles":"O=[As](O)(O)c1ccc(NCCNc2ccc([As](=O)(O)O)cc2)cc1","inchiKey":"YQVALJGIKVYRNI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFETARSONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anhydrous difetarsone sodium","Difetarsone","Difetarsone sodium","Difetarsone sodium anhydrous","Diphetarsone","N,n-ethylenediarsanilic acid","RP 4763 [AS SODIUM SALT)"],"crossReferences":{"drugbank":["DB13599"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL180300","canonicalSmiles":"C[C@@H](COc1ccc([C@@H]2Oc3ccc(O)cc3S[C@@H]2c2ccc(O)cc2)cc1)N1CCCC1","inchiKey":"UZOOIPXOYYJULJ-RHLLTPQKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL180300","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02715"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1817968","canonicalSmiles":"CC(C)(C)c1cc(C(C)(C)C)c2[nH]c(C(C)(C)C)c(C[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc3ccccc3)c2c1","inchiKey":"ZVOYWSKEBVVLGW-ZDCRTTOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LTX-109","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ltx-109"],"crossReferences":{"drugbank":["DB12711"],"chEBI":["77752"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1819440","canonicalSmiles":"NCCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N1)C(=O)NCC(N)=O","inchiKey":"MUNMIGOEDGHVLE-LGYYRGKSSA-N","drugType":"Protein","blackBoxWarning":false,"name":"ORNIPRESSIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8-l-ornithinevasopressin","8-ornithinevasopressin","Orn(8)-vasopressin","Ornipressin","Ornithine vasopressin","Orpressin","POR 8","POR-8","Por 8 sandoz"],"crossReferences":{"drugbank":["DB13464"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL185097","canonicalSmiles":"CCCC[C@H](NC(=O)OCC1(Cc2ccc(F)cc2)CCC1)C(=O)C(=O)Nc1ccn[nH]1","inchiKey":"QTPYRNAKLBXKNP-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL185097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01858"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1892286","canonicalSmiles":"CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H](C(C)=O)[C@@]4(C)CC[C@@H]32)C1","inchiKey":"CRRKVZVYZQXICQ-RJJCNJEVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1892286","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11532887","144206911"],"drugbank":["DB14626"],"chEBI":["34930"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908355","canonicalSmiles":"NC(=O)N1C(=O)/C(=C(\\O)c2cccs2)c2cc(Cl)ccc21","inchiKey":"LXIKEPCNDFVJKC-QXMHVHEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENIDAP","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-66,248","CP-66248","Tenidap"],"crossReferences":{"drugbank":["DB13481"],"chEBI":["35847"]},"childChemblIds":["CHEMBL2104833"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL202839","canonicalSmiles":"CC1(C)SCCN(S(=O)(=O)c2ccc(OCC#CCN)cc2)[C@H]1C(=O)NO","inchiKey":"AANXPIMDONQTQF-HNNXBMFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL202839","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07121"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2028663","canonicalSmiles":"CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1","inchiKey":"BFSMGDJOXZAERB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DABRAFENIB","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tafinlar"],"synonyms":["Dabrafenib","GSK-2118436","GSK-2118436A","GSK2118436A","Gsk2118436"],"crossReferences":{"DailyMed":["dabrafenib%20mesylate"],"drugbank":["DB08912"],"chEBI":["75045"]},"childChemblIds":["CHEMBL2105729"],"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","MONDO_0100342","MONDO_0002108","EFO_0000756","EFO_1000926","EFO_1001968","EFO_0003060","EFO_0000311","EFO_0006772","EFO_1001480","EFO_0002892","EFO_0000389","MONDO_0008903","EFO_0001421","EFO_0000501","EFO_0000641","EFO_0001378","MONDO_0024880","EFO_0003833","MONDO_0021637","EFO_0002617","MONDO_0017795"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 7 approved and 18 investigational indications."}
{"id":"CHEMBL2096895","canonicalSmiles":"Nc1ncnc2c1ncn2CCOC[P@@]1(=O)OCC[C@@H](c2cccc(Cl)c2)O1","inchiKey":"GWNHAOBXDGOXRR-HJFSHJIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRADEFOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pradefovir"],"crossReferences":{"drugbank":["DB15550"]},"childChemblIds":["CHEMBL3989658"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103772","canonicalSmiles":"CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc1ccccc1","inchiKey":"ODUOJXZPIYUATO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RACECADOTRIL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hidrasec"],"synonyms":["Acetorphan","NSC-759828","Racecadotril","Tiorfan","Tiorfix"],"crossReferences":{"PubChem":["174006909"],"drugbank":["DB11696"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104194","canonicalSmiles":"COC(=O)CCC=C=CC[C@H]1C(=O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1ccccc1","inchiKey":"PTOJVMZPWPAXER-VFJVYMGBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENPROSTIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Gardrin"],"synonyms":["Camleed","Enprostil","RS-84135"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2104955","canonicalSmiles":"C=C1[C@H](O)CC(=C/C=C2\\CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@@H](C)CC)C[C@H]1O","inchiKey":"QSLUXQQUPXBIHH-YHSKWIAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BECOCALCIDIOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2MBisP","Becocalcidiol","DP-006","DP006","QRX 101","QRX-101","Qrx-101"],"crossReferences":{"drugbank":["DB04891"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000676"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106003","canonicalSmiles":"CC(C)(C)CCC#C[C@@H]1C[C@H]1c1c[nH]cn1.O=C(O)/C=C\\C(=O)O","inchiKey":"QIQWRCNAPQJQLL-COALEZEGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIPRALISANT MALEATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL278462","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Perceptin"],"synonyms":["Cipralisant maleate","GT-2331","Gt2331"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106566","canonicalSmiles":"O=P([O-])([O-])[O-].O=P([O-])([O-])[O-].[Ca+2].[Ca+2].[Ca+2]","inchiKey":"QORWJWZARLRLPR-UHFFFAOYSA-H","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM PHOSPHATE, TRIBASIC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bone ash","Bone powder, purified","Calcium phosphate","Calcium phosphate, tribasic","Durapatite","E-341(III)","FEMA NO. 3081","INS NO.341(III)","INS-341(III)","Tribasic calcium phosphate","WIN 40350","WIN-40350"],"crossReferences":{"drugbank":["DB11348"],"chEBI":["9679"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106939","canonicalSmiles":"CCCCCCNC(=N)NC(=N)N","inchiKey":"VAZJLPXFVQHDFB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLIHEXANIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cosmocil cq","Lavasept","Microcare mbg","Polihexanide","Polihexanide hydrochloride","Poly(hexamethylenebiguanide)","Polyhexamethylene biguanide","Polyhexanide","Purista","Vantocil"],"crossReferences":{"DrugCentral":["4692"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2107430","canonicalSmiles":"Fc1ccc(C(c2ccccc2)(c2ccccc2F)n2ccnc2)cc1","inchiKey":"QHMWCHQXCUNUAK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUTRIMAZOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Micetal"],"synonyms":["Flutrimazole","UR-4056"],"crossReferences":{"drugbank":["DB13425"],"chEBI":["82864"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2108151","drugType":"Antibody","blackBoxWarning":false,"name":"NACOLOMAB TAFENATOX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nacolomab tafenatox"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2108558","drugType":"Small molecule","blackBoxWarning":false,"name":"SENNA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Califig","Manevac","Sennoside b","Senokot","Senokot max strgh","Sure-lax","X-prep"],"synonyms":["Afrikanskaya senna leaf","Afrikanskaya senna whole","Alexandria senna","Alexandrian senna leaf","Alexandrian senna whole","B2056","Bhuikhakhasa leaf","Bhuikhakhasa whole","Bombay senna leaf","Bombay senna whole","Casse leaf","Casse whole","Cassia acutifolia leaf","Cassia acutifolia whole","Cassia alexandrina leaf","Cassia angustifolia leaf","Cassia angustifolia vahl","Cassia lanceolata leaf","Cassia senna l.","Cassia senna leaf","Ennae folium","Fan xie ye","Fanxieye (cassia angustifolia)","Hindisana leaf","Hindisana whole","Indian senna leaf","Indian senna whole","Jalelo leaf","Jalelo whole","Kassiya ostrolistnaya leaf","Kassiya ostrolistnaya whole","NSC-112930","Sana leaf","Sana whole","Senna","Senna acutifolia leaf","Senna acutifolia whole","Senna alexandrina","Senna alexandrina dry leaf","Senna alexandrina leaf","Senna alexandrina leaf dry extract","Senna alexandrina leaf extract","Senna alexandrina leaf powder","Senna alexandrina whole","Senna angustifolia leaf","Senna concentrate","Senna extract","Senna glycosides","Senna leaf","Senna leaf (cassia angustifolia)","Senna whole","Senna-i-makki leaf","Senna-i-makki whole","Sennae folium","Sennae folium concisum","Sennosides sennoside b","Standardized senna concentrate","Svarnapatri leaf","Svarnapatri whole","Tinnevelly senna","Tinnevelly senna leaf","Tinnevelly senna whole","True senna leaf","True senna whole","Xia ye fan xie"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and constipation disorder and has 1 investigational indication."}
{"id":"CHEMBL2108585","drugType":"Gene","blackBoxWarning":false,"name":"CONTUSUGENE LADENOVEC","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Advexin"],"synonyms":["AD5CMV-P53","Contusugene ladenovec","INGN 201"],"linkedTargets":{"rows":["ENSG00000141510"],"count":1},"linkedDiseases":{"rows":["MONDO_0002691","EFO_0000616","EFO_0006859","MONDO_0008903","MONDO_0008170","MONDO_0007254","MONDO_0002087","MONDO_0004986","EFO_0003060","MONDO_0001187","EFO_1000158"],"count":11},"description":"Gene drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2109000","drugType":"Unknown","blackBoxWarning":false,"name":"CARBOXYMETHYLCELLULOSE CALCIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium carboxy methyl cellulose","Calcium carboxymethyl cellulose","Carbose","Carboxymethyl cellulose","Carboxymethylated cellulose pulp","Carboxymethylcellulose","Carboxymethylcellulose calcium","Carmellose","Carmellose calcium","Cellulose carboxymethyl ether","Cellulose, carboxymethyl ether","Glycocel ta","Intrasite gel","Thylose"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109263","drugType":"Antibody","blackBoxWarning":false,"name":"ING-1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HEMAB","ING-1","Ing-1"],"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["EFO_0000228"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2109417","drugType":"Antibody","blackBoxWarning":false,"name":"EMD-273063","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APN301","Apn-301","EMD 273063","EMD-273063","Emd-273063","HU14.18-IL2","Hu 14.18il2","Hu14.18-il2","Lorukafusp alfa"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109556","drugType":"Antibody","blackBoxWarning":false,"name":"MLN-2704","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MLN-2704","MLN-591DM1","Mln-2704"],"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["EFO_0000673","MONDO_0008315"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109600","drugType":"Antibody","blackBoxWarning":false,"name":"RO-5458640","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RG-7212","RO-5458640","Ro-5458640"],"linkedTargets":{"rows":["ENSG00000239697"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109629","drugType":"Antibody","blackBoxWarning":false,"name":"ANETUMAB RAVTANSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anetumab ravtansine","BAY 94-9343","BAY-94-9343","BAY-949343","BAY94-9343"],"linkedTargets":{"rows":["ENSG00000102854"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_1000044","EFO_0003893","EFO_0000588","EFO_0000770","MONDO_0021117","EFO_0003060","EFO_0000311"],"count":9},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2110551","drugType":"Small molecule","blackBoxWarning":false,"name":"TECHNETIUM PENTETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["technetium%20tc-99m%20pentetate%20kit"]},"childChemblIds":["CHEMBL2096656"],"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL220896","canonicalSmiles":"Nc1ncccc1NCc1cccc(-c2ccc3cc[nH]c3c2)c1","inchiKey":"LPQUIIHPUGDHJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220896","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07993"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL231095","canonicalSmiles":"c1ccc(Nc2nc(Nc3ccccc3)n3nccc3n2)cc1","inchiKey":"LLYYAUZAGCZEKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL231095","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08340"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL231813","canonicalSmiles":"CCC[C@H](NC(=O)[C@@H]1[C@H]2CCC[C@H]2CN1C(=O)[C@@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(C)(C)C)C(=O)C(=O)NC1CC1","inchiKey":"BBAWEDCPNXPBQM-GDEBMMAJSA-N","drugType":"Protein","blackBoxWarning":true,"name":"TELAPREVIR","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Incivek","Incivo"],"synonyms":["LY 570310","LY-570310","MP 424","MP-424","Telaprevir","VRT 111950","VRT-111950","VX 950","VX-950"],"crossReferences":{"Wikipedia":["Telaprevir"],"drugbank":["DB05521"],"chEBI":["68595"]},"childChemblIds":["CHEMBL573043"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and is indicated for viral disease and has 6 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2364626","canonicalSmiles":"CC(C)(C)Cn1c(N)nc2ccc(-c3[nH]c(C(C)(C)C)nc3-c3ccc(F)cc3)nc21","inchiKey":"XPPBBJCBDOEXDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RALIMETINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LSN-2322600 FREE BASE","LSN2322600 FREE BASE","LY-2228820","LY2228820","LY22288220","Ly-2228820","Ralimetinib"],"crossReferences":{"drugbank":["DB11787"]},"childChemblIds":["CHEMBL2364627"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","MONDO_0015686","MONDO_0008170","MONDO_0007254","EFO_0000519","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL23832","canonicalSmiles":"O=C(O)c1ccccc1Nc1ccccc1","inchiKey":"ZWJINEZUASEZBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENAMIC ACID ","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(Phenylamino)Benzoic Acid","2-Phenylamino-Benzoic Acid","Fenamic acid ","N-Phenylanthranilic Acid"],"crossReferences":{"PubChem":["11110659","124878982","124878985","26747414","26753504","26753505","50105728","50105729","56463797","85230871","90341494"],"TG-GATEs":["140"],"Wikipedia":["Fenamic_acid"],"chEBI":["34756"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2448613","canonicalSmiles":"CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"RGSULKHNAKTFIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PIMAVANSERIN TARTRATE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2111101","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nuplazid"],"synonyms":["ACP-103","Pimavanserin tartrate"],"crossReferences":{"DailyMed":["pimavanserin%20tartrate"]},"linkedTargets":{"rows":["ENSG00000102468"],"count":1},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0005180","MONDO_0004975","EFO_0005407","HP_0000738"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL254071","canonicalSmiles":"COc1cc(C[C@H](C)[C@H](C)Cc2ccc3c(c2)OCO3)ccc1O","inchiKey":"QDDILOVMGWUNGD-UONOGXRCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AUSTROBAILIGNAN 6","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Austrobailignan 6"],"crossReferences":{"PubChem":["26725241"],"drugbank":["DB14129"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL269732","canonicalSmiles":"C=CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC","inchiKey":"QJJXYPPXXYFBGM-LFZNUXCKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TACROLIMUS","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prograf","Protopic","Tacrolimus"],"synonyms":["FK-506","FK506","FR-900506","NSC-758659","Tacrolimus monohydrate"],"crossReferences":{"DailyMed":["tacrolimus"],"PubChem":["144205609","50111459"],"drugbank":["DB00864"],"chEBI":["61049"]},"childChemblIds":["CHEMBL3989887"],"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_1000668","EFO_0001423","EFO_0004228","EFO_0005952","EFO_1000623","EFO_0006803","EFO_1000318","MONDO_0015760","EFO_0006344","EFO_0000339","EFO_0000096","EFO_1000956","Orphanet_3319","EFO_0003884","EFO_0007157","EFO_1000652","EFO_0000676","EFO_0004991","MONDO_0004976","EFO_0008517","EFO_0000400","Orphanet_42738","MONDO_0000159","EFO_0000198","MONDO_0013730","EFO_0005803","MONDO_0019465","EFO_0001642","HP_0000964","HP_0001410","EFO_0004286","EFO_1001946","EFO_1000309","EFO_0000384","MONDO_0008315","Orphanet_567","HP_0001399","EFO_0000546","EFO_0001422","MONDO_0009453","MONDO_0044889","EFO_0003032","Orphanet_79364","MONDO_0019472","EFO_0000574","MONDO_0004979","EFO_0001378","Orphanet_231214","EFO_1000550","EFO_0001062","EFO_0003086","MONDO_0044903","EFO_0001365","EFO_0007183","EFO_0007451","EFO_0000255","EFO_1001413","MONDO_0016236","EFO_1000794","MONDO_0003541","EFO_0002430","EFO_0005676","EFO_1001996","MONDO_0002898","EFO_0000183","Orphanet_447","EFO_1000388","HP_0012115","EFO_0000616","EFO_1001779","MONDO_0019457","EFO_0000403","EFO_0004198","EFO_0000222","EFO_0000319","MONDO_0000870","EFO_0003818","MONDO_0019469","EFO_0004599","EFO_0003896","EFO_0004220","EFO_0000512","Orphanet_774","EFO_0006927","EFO_1001947","MONDO_0002367","EFO_0007141","MONDO_0018906","EFO_0000763","MONDO_0005148","EFO_0003872","EFO_0000729","MONDO_0000873","EFO_0003777","Orphanet_183660","EFO_0011057","MONDO_0000956","EFO_0009373","EFO_1000131","Orphanet_848","Orphanet_79383","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0004251","EFO_0007160","EFO_0000544","MONDO_0019088","EFO_0000182","EFO_0000330","EFO_0004255","EFO_0004208","MONDO_0004768","EFO_1000785","EFO_0009441","EFO_0005761","HP_0003124","EFO_0000220","EFO_0002687","EFO_0004236","EFO_0004194","MONDO_0044881","EFO_0002429","Orphanet_811","MONDO_0019474","MONDO_0100096","MONDO_0021193","EFO_0002428","EFO_1001051","MONDO_0002334","MONDO_0019471","Orphanet_232","EFO_1000965","EFO_1000764","EFO_1001020","EFO_0000274","HP_0001915","EFO_1001469","EFO_1002048","EFO_1000690","HP_0000083","Orphanet_906","EFO_0004254","EFO_0003144","EFO_1001993","EFO_0003047","EFO_0000717","EFO_0000685","EFO_0000545","EFO_0000621","EFO_0000311","MONDO_0001705","EFO_0000211","EFO_0003834","MONDO_0005301","EFO_0000095","EFO_0006475","MONDO_0005147","EFO_0001421","EFO_0009510","MONDO_0020077","EFO_0000691","HP_0012410"],"count":164},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for immune system disease and eczema and has 122 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL278623","canonicalSmiles":"CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O","inchiKey":"UJVDJAPJQWZRFR-DHIUTWEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MACIMORELIN","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Macrilen","Solorel"],"synonyms":["AEZS-130","ARD-07","Ard-07","EP-01572","EP-1572","EP01572","JMV 1843","JMV-1843","Macimorelin"],"crossReferences":{"DailyMed":["macimorelin%20acetate"],"drugbank":["DB13074"]},"childChemblIds":["CHEMBL2364617"],"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["HP_0004326"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2017 and has 1 investigational indication."}
{"id":"CHEMBL280541","canonicalSmiles":"C[C@H](Sc1nc(N)cc(Cl)n1)c1cc2ccoc2cn1","inchiKey":"ATCRIOJPQXDFNY-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PNU-142721","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PNU-142721"],"crossReferences":{"drugbank":["DB08414"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284733","canonicalSmiles":"N#CC(c1ccc(Cl)cc1)c1c(Cl)cc(-n2ncc(=O)[nH]c2=O)cc1Cl","inchiKey":"ZSZFUDFOPOMEET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DICLAZURIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clinacox","Diclazuril","Diclazuril for veterinary use","NSC-759642","Nuoqiu","P-64433","R-64-433","R-64433","R64,433","Vecoxan"],"crossReferences":{"PubChem":["144206198","50113287"],"Wikipedia":["Diclazuril"],"drugbank":["DB11398"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL287837","canonicalSmiles":"Clc1ccc2c(c1Cl)CNCC2","inchiKey":"WFPUBEDBBOGGIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SK&F-64139","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SK&F-64139","SK-64139"],"crossReferences":{"drugbank":["DB08550"],"chEBI":["160129"]},"childChemblIds":["CHEMBL541797"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL289351","canonicalSmiles":"COc1ccc(/C=C\\c2cc(OC)c(OC)c(OC)c2)cc1OP(=O)([O-])[O-].[Na+].[Na+]","inchiKey":"VXNQMUVMEIGUJW-XNOMRPDFSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSBRETABULIN DISODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1206232","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CA 4P","CA-4DP","CA4DP","Fosbretabulin disodium","Fosbretabulin disodium salt"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_0004683","EFO_0006859","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL290960","canonicalSmiles":"CC1CS(=O)(=O)CCN1/N=C/c1ccc([N+](=O)[O-])o1","inchiKey":"ARFHIAQFJWUCFH-IZZDOVSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFURTIMOX","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lampit"],"synonyms":["BAY 2502","BAY A2502","BAY-2502","BAY-A2502","BAYER 2502","BAYER-2502","DNDI1613515","Nifurtimox","Nifurtimoxum"],"crossReferences":{"Wikipedia":["Nifurtimox"],"drugbank":["DB11820"],"chEBI":["7566"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 4 approved and 2 investigational indications."}
{"id":"CHEMBL295069","canonicalSmiles":"NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](OP(=O)(O)O)[C@@H]3O)[C@@H](O)[C@H]2O)c1","inchiKey":"XJLXINKUBYWONI-NNYOXOHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM beta-NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03461"],"chEBI":["44409"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL295666","canonicalSmiles":"N[C@H](CCl)C(=O)O","inchiKey":"ASBJGPTTYPEMLP-UWTATZPHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL295666","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11111003"],"drugbank":["DB01735"],"chEBI":["17092"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL303958","canonicalSmiles":"Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1","inchiKey":"DGWXOLHKVGDQLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NU-6027","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NU-6027"],"crossReferences":{"PubChem":["29217602","49674690","529470","90340579"],"drugbank":["DB08312"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3113974","canonicalSmiles":"CS(=O)(=O)Nc1ccc(C(=O)O[C@@H](Cc2c(Cl)c[n+]([O-])cc2Cl)c2ccc(OC(F)F)c(OCC3CC3)c2)cc1OCC1CC1","inchiKey":"VCFBPAOSTLMYIV-SANMLTNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHF-6001","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHF6001","Chf-6001","Chf6001","J3.309.618F","Tanimilast"],"crossReferences":{"drugbank":["DB12800"]},"linkedTargets":{"rows":["ENSG00000065989","ENSG00000105650","ENSG00000113448","ENSG00000184588"],"count":4},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3126004","canonicalSmiles":"C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O)Oc1ccccc1)C(=O)OCc1ccccc1","inchiKey":"NHTKGYOMICWFQZ-KKQYNPQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSGEMCITABINE PALABENAMIDE, P(RS)-","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acelarin","CPF-31","Fosgemcitabine palabenamide, p(rs)-","Gemictabine protide","NUC-1031","Nuc-1031"],"crossReferences":{"drugbank":["DB15057"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL316157","canonicalSmiles":"O=C(Cc1cccs1)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12","inchiKey":"CZTQZXZIADLWOZ-CRAIPNDOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHALORIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Kefloridin","Loridine"],"synonyms":["40602","Cefaloridine","Cephaloridine"],"crossReferences":{"PubChem":["144204921"],"Wikipedia":["Cephaloridine"],"drugbank":["DB09008"],"chEBI":["3537"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3391662","canonicalSmiles":"Cc1cnc(C(=O)N[C@H]2CCCCC/C=C\\[C@@H]3C[C@@]3(C(=O)NS(=O)(=O)C3CC3)NC(=O)[C@@H]3C[C@@H](Oc4nc5ccccc5c5ccccc45)CN3C2=O)cn1","inchiKey":"UAUIUKWPKRJZJV-QPLHLKROSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARITAPREVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ABT-450","Paritaprevir","Veruprevir","Veruprevir anhydrous"],"crossReferences":{"drugbank":["DB09297"]},"childChemblIds":["CHEMBL3781660"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for chronic hepatitis c virus infection and hepatitis c virus infection and has 1 investigational indication."}
{"id":"CHEMBL3417258","canonicalSmiles":"CC(C)C(=O)OC[C@@]1(CCl)O[C@@H](n2ccc(N)nc2=O)[C@H](F)[C@@H]1OC(=O)C(C)C","inchiKey":"MJVKYGMNSQJLIN-KYZVSKTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUMICITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALS-008176","Als-8176","Lumicitabine"],"crossReferences":{"drugbank":["DB14808"]},"childChemblIds":["CHEMBL4752073"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL345248","canonicalSmiles":"BrC(Br)Br","inchiKey":"DIKBFYAXUHHXCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOFORM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bromoform"],"crossReferences":{"PubChem":["144207387","17389702"],"Wikipedia":["Bromoform"],"drugbank":["DB03054"],"chEBI":["38682"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545213","canonicalSmiles":"N#CC(c1ccnc(OCc2ccc(CN3CCOCC3)cc2)n1)c1nc2ccccc2s1","inchiKey":"XCPPIJCBCWUBNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENTAMAPIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["As-602801","Bentamapimod","PGL-5001"],"linkedTargets":{"rows":["ENSG00000107643","ENSG00000050748","ENSG00000109339"],"count":3},"linkedDiseases":{"rows":["EFO_0001065"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3585580","canonicalSmiles":"COc1ccc(Oc2cc(N(C)CCOc3ccc(CC4SC(=O)NC4=O)cc3)ncn2)cc1","inchiKey":"CHHXEZSCHQVSRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LOBEGLITAZONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lobeglitazone"],"crossReferences":{"drugbank":["DB09198"]},"childChemblIds":["CHEMBL3780740"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL360563","canonicalSmiles":"CCc1cc(-c2n[nH]cc2-c2c[nH]cn2)c(O)cc1O","inchiKey":"ATORUNMAUREKMH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360563","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03749"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3651966","canonicalSmiles":"C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1","inchiKey":"VRQXRVAKPDCRCI-ZNMIVQPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3651966","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14943"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL36994","canonicalSmiles":"COc1ccc(C(=O)N2CCCC2=O)cc1","inchiKey":"ZXNRTKGTQJPIJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANIRACETAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-p-anisoyl-2-pyrrolidinone","Ampamet","Aniracetam","Draganon","Memodrin","NSC-758223","RO 13-5057","RO-13-5057","RO-135057","Sarpul"],"crossReferences":{"PubChem":["104171112","11113324","144203637","170465854","26746909","50103913","855554","856168"],"Wikipedia":["Aniracetam"],"drugbank":["DB04599"],"chEBI":["47943"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707299","canonicalSmiles":"NC(CO)(CO)CO.O=C(O[Al](O)O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"GJJYZOBRHIMORS-GQOAHPRESA-K","drugType":"Small molecule","blackBoxWarning":false,"name":"ALOGLUTAMOL","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3707300","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aloglutamol","Altris","Pyreses","Sabro","Tasto"],"crossReferences":{"DrugCentral":["4759"],"drugbank":["DB13650"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707307","canonicalSmiles":"CCOc1ccc2nc(SCCN3CCOCC3)[nH]c2c1","inchiKey":"WWNUCVSRRUDYPP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FABOMOTIZOLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afobazol","Afobazole","Aphobazole","CM-346","Fabomotizole","Obenoxazine"],"crossReferences":{"drugbank":["DB13623"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3707396","drugType":"Small molecule","blackBoxWarning":false,"name":"EVT401","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evt401"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL371197","canonicalSmiles":"O[C@@H]1[C@H](O)CN2CCC[C@@H](O)[C@H]12","inchiKey":"FXUAIOOAOAVCGD-WCTZXXKLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIDOLGOSIR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Swainsonine","Tridolgosir"],"crossReferences":{"PubChem":["144205611","26756869","487039","50111467"],"Wikipedia":["Swainsonine"],"drugbank":["DB02034"],"chEBI":["9367"]},"childChemblIds":["CHEMBL2107226"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL371428","canonicalSmiles":"C#CCN[C@@H]1CCc2ccc(O)cc21","inchiKey":"NRSDGDXUWMMUEV-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL371428","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04307"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL379692","canonicalSmiles":"COc1cc(C)c(S(=O)(=O)NC[C@@H](O)[C@@H](N)Cc2ccccc2)c(C)c1C","inchiKey":"HORGTFOBJRCVMO-ZWKOTPCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL379692","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07527"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3833385","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc3c(c2)O[C@@H](c2cnc(C4CC4)s2)n2c-3cc3cc(-c4c[nH]c([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)n4)ccc32)c[nH]1)C(C)C","inchiKey":"LTSZWQVAHDFPNW-PRMCSTHUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUZASVIR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-8408","Ruzasvir"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL383824","canonicalSmiles":"CO[C@H]1/C=C\\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@@H]1OC(N)=O)C2=O","inchiKey":"KUFRQPKVAWMTJO-LMZWQJSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVESPIMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alvespimycin","NSC-707545"],"crossReferences":{"Wikipedia":["17-Dimethylaminoethylamino-17-demethoxygeldanamycin"],"drugbank":["DB12442"],"chEBI":["65324"]},"childChemblIds":["CHEMBL2105630"],"linkedTargets":{"rows":["ENSG00000080824","ENSG00000096384"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001023","EFO_0000095","MONDO_0007254"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL391586","canonicalSmiles":"N#Cc1c(-c2ccccc2)cc(-c2cc(Br)ccc2O)[nH]c1=O","inchiKey":"SVSYJTYGPLVUOZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL391586","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08705"],"chEBI":["86453"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL398880","canonicalSmiles":"CN(C)S(=O)(=O)c1ccc2c(c1)N(CCCN1CCC(CCO)CC1)c1ccccc1S2","inchiKey":"JOMHSQGEWSNUKU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPOTIAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Pipotiazine"],"drugbank":["DB01621"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989523","canonicalSmiles":"N=C(N)NCc1cccc([123I])c1.N=C(N)NCc1cccc([123I])c1.O=S(=O)(O)O","inchiKey":"XNACDNPGABUBFR-FKNPGSCZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOBENGUANE SULFATE I 123","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL818","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adreview"],"synonyms":["Iobenguane i 123 hemisulfate","Iobenguane i 123 hemisulphate","Iobenguane i-123 hemisulfate","Iobenguane i-123 hemisulphate","Iobenguane sulfate i 123","Iobenguane sulfate i-123","Iobenguane sulphate i 123","Iobenguane sulphate i-123","Iobenguane, i-123 hemisulfate","Iobenguane, i-123 hemisulphate","Iodobenzylguanidine sulfate i 123","Mibg-i-123"],"crossReferences":{"DailyMed":["iobenguane%20sulfate%20i-123"],"drugbank":["DB09546"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008."}
{"id":"CHEMBL3989714","canonicalSmiles":"CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.O=S(=O)(O)O","inchiKey":"SBKRTALNRRAOJP-BWSIXKJUSA-N","drugType":"Protein","blackBoxWarning":true,"name":"POLYMYXIN B SULFATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3989738","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerosporin","Gppe pdr ster","Poly-rx","Polyfax","Polymycin b sulfate","Polymyxin b sulfate","Polytrim","Thiosporin"],"synonyms":["NSC-757278","Polymixin b sulfate","Polymixin b sulphate","Polymyxin b sulfate","Polymyxin b sulphate","Polymyxin b, sulfate","Polymyxin b, sulphate"],"crossReferences":{"DailyMed":["polymyxin%20b%20sulfate"]},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989821","canonicalSmiles":"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.Cl.O.O.O.O.O.[Cl-]","inchiKey":"WMIZITXEJNQAQK-GGDSLZADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUBOCURARINE CHLORIDE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL339427","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jexin","Tubarine","Tubocurarine chloride"],"synonyms":["Curare","NSC-757362","Tubaine","Tubarine pentahydrate","Tubocurarine chloride","Tubocurarine chloride anhydrous","Tubocurarine chloride, anhydrous","Tubocurarini chloridum"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1945."}
{"id":"CHEMBL3989868","canonicalSmiles":"Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1","inchiKey":"SDEAXTCZPQIFQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUCATINIB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tukysa"],"synonyms":["ARRY-380","Irbinitinib","ONT-380","Ont-380","Tucatinib"],"crossReferences":{"DailyMed":["tucatinib"],"drugbank":["DB11652"]},"linkedTargets":{"rows":["ENSG00000141736"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0000305","EFO_0003060","EFO_0000311","MONDO_0001056","EFO_1001480","EFO_1000294","EFO_0000339","EFO_0003968","EFO_0005537","EFO_0001421","EFO_0004142","EFO_0003833"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 6 approved and 4 investigational indications."}
{"id":"CHEMBL3990145","canonicalSmiles":"COCCCCn1c(C(=O)N(CC(C)C)[C@@H]2CNC[C@H](C(=O)N3CCOCC3)C2)nc2ccccc21","inchiKey":"RHIBAIKQWJNESW-YADHBBJMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IMARIKIREN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Imarikiren"],"childChemblIds":["CHEMBL3969876"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL406821","canonicalSmiles":"Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12","inchiKey":"AWDORCFLUJZUQS-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"H-1152P","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["H-1152P"],"crossReferences":{"drugbank":["DB07876"],"chEBI":["88220"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4227721","canonicalSmiles":"CCOC(=O)O[C@@H](C)n1nnnc1-c1c(-c2ccc(C(=O)N(c3ncccc3Cl)[C@@H]3CCCNC3)cc2F)cnn1C","inchiKey":"QTBYVAZRKWOIDU-FUHWJXTLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06815345","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-06815345","Pf-06815345"],"crossReferences":{"drugbank":["DB14862"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL428676","canonicalSmiles":"CN(C)CCN1C(=O)c2cccc3cc(N)cc(c23)C1=O","inchiKey":"UPALIKSFLSVKIS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMONAFIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1413","Amonafide","NSC-308847","Nafidimide"],"crossReferences":{"PubChem":["454647"],"Wikipedia":["Amonafide"],"drugbank":["DB05022"]},"childChemblIds":["CHEMBL1910266","CHEMBL538838","CHEMBL2104952"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297163","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"MUPARFOSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Muparfostat","PI-88"],"childChemblIds":["CHEMBL4297162"],"linkedTargets":{"rows":["ENSG00000138685","ENSG00000113578","ENSG00000173083","ENSG00000112715"],"count":4},"linkedDiseases":{"rows":["EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000756","EFO_0003060","MONDO_0008315"],"count":6},"description":"Oligosaccharide drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297185","canonicalSmiles":"CC(O)c1cc(C(=O)N[C@@H](C)Cn2ccc(-c3ccc(C#N)c(Cl)c3)n2)n[nH]1","inchiKey":"BLIJXOOIHRSQRB-PXYINDEMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAROLUTAMIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nubeqa"],"synonyms":["BAY 1841788","BAY-1841788","BAY1841788","Darolutamide","ODM-201","Odm-201"],"crossReferences":{"DailyMed":["darolutamide"],"drugbank":["DB12941"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000673","EFO_0000196","MONDO_0007254","MONDO_0008315","EFO_0001663","EFO_0000311"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 6 approved and 2 investigational indications."}
{"id":"CHEMBL4297347","drugType":"Unknown","blackBoxWarning":false,"name":"DOTAMTATE PB-212","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4300858","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["212pb-dotamtate","Alphamedix","Dotamtate lead pb-212","Dotamtate pb-212","Lead-212 dotamtate"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297440","canonicalSmiles":"COc1ccc(NS(=O)(=O)c2c(F)c(F)c(F)c(F)c2F)cc1NC(N)=O","inchiKey":"FSXLOWIFSZNIMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"T-900607","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["T 900607","T-900607","T900607"],"crossReferences":{"drugbank":["DB12068"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000137285","ENSG00000123416","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["MONDO_0002691","MONDO_0001056","EFO_0003893","EFO_0000182","EFO_0005952"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297454","canonicalSmiles":"CCNC(=O)c1cc2c(-c3cc(C(C)(C)O)ccc3Oc3c(C)cc(F)cc3C)cn(C)c(=O)c2[nH]1","inchiKey":"OEDSFMUSNZDJFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABBV-744","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABBV-744","Abbv-744"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297535","drugType":"Unknown","blackBoxWarning":false,"name":"FISH OIL TRIGLYCERIDES","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omegaven"],"synonyms":["Fish oil triglycerides"],"crossReferences":{"DailyMed":["fish%20oil%20triglycerides"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for cholestasis and has 9 investigational indications."}
{"id":"CHEMBL4297559","drugType":"Unknown","blackBoxWarning":false,"name":"HILTONOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hiltonol","Poly(iclc)","Poly-iclc"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 23 investigational indications."}
{"id":"CHEMBL4297579","drugType":"Gene","blackBoxWarning":false,"name":"VALOCTOCOGENE ROXAPARVOVEC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMN-270","BMN270","Valoctocogene roxaparvovec"],"description":"Gene drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297826","drugType":"Unknown","blackBoxWarning":false,"name":"SGN-CD123A","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SGN-CD123A","Sgn-cd123a"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297839","drugType":"Protein","blackBoxWarning":false,"name":"TIRZEPATIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-3298176","LY3298176","Ly3298176","Tirzepatide"],"linkedTargets":{"rows":["ENSG00000112164","ENSG00000010310"],"count":2},"linkedDiseases":{"rows":["EFO_1001249","MONDO_0005148","EFO_0001073","EFO_0000400"],"count":4},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297850","drugType":"Antibody","blackBoxWarning":false,"name":"XENTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 836845","BI-836845","Bi 836845","Xentuzumab"],"linkedTargets":{"rows":["ENSG00000167244","ENSG00000017427"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000673","EFO_0003060","MONDO_0008315"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297944","drugType":"Unknown","blackBoxWarning":false,"name":"EDI-200","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APO200","EDI-200","EDI200","Edi-200","Edi200","Fc:eda-a1 fusion protein"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297973","drugType":"Unknown","blackBoxWarning":false,"name":"HEPATITIS B VIRUS HBSAG SURFACE PROTEIN ANTIGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adsorbed hepatitis b vaccine","Hbsag","Hepatitis b antigen","Hepatitis b surface antigen","Hepatitis b surface antigens","Hepatitis b vaccine","Hepatitis b vaccine (recombinant)","Hepatitis b vaccine recombinant","Hepatitis b virus hbsag surface protein antigen","Hepatitis b virus vaccine","Hepatitis-b surface antigen"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL4298099","drugType":"Unknown","blackBoxWarning":false,"name":"SAR-439459","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GC-2008","GC2008","SAR-439459","SAR439459","Sar-439459","Sar439459"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298118","drugType":"Unknown","blackBoxWarning":false,"name":"PREIMPLANTATION FACTOR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pif-1","Preimplantation factor","Synthetic preimplantation factor"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL43048","canonicalSmiles":"CNC(C)Cc1ccc2c(c1)OCO2","inchiKey":"SHXWCVYOXRDMCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIDOMAFETAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Methylenedioxymethamphetamine","3,4-methylenedioxymetamphetamine","Ecstasy","Mdma","Methylenedioxy Methamphetamine","Methylenedioxymetamphetamine","Methylenedioxymethamfetamine","Methylenedioxymethamphetamine","Midomafetamine"],"crossReferences":{"Wikipedia":["MDMA"],"drugbank":["DB01454"],"chEBI":["1391"]},"childChemblIds":["CHEMBL3189075"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL43068","canonicalSmiles":"CC(C)[C@H](N)C(=O)O","inchiKey":"KZSNJWFQEVHDMF-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-valine","NSC-76038","Valine"],"crossReferences":{"Wikipedia":["Valine"],"drugbank":["DB00161"],"chEBI":["16414"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL453280","canonicalSmiles":"COc1ccc2c(=O)c(-c3ccc(O)cc3)coc2c1","inchiKey":"LNIQZRIHAMVRJA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOFORMONENTIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoformonentin"],"crossReferences":{"drugbank":["DB04202"],"chEBI":["29608"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL456929","canonicalSmiles":"CNC(=O)CCC(=O)N[C@@H](Cc1ccccc1)[C@H](O)CN(CC1CC1)S(=O)(=O)c1ccco1","inchiKey":"IKOPFHKAECNGQI-VQTJNVASSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL456929","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08223"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4592045","canonicalSmiles":"CCc1cc(F)c2nc(N3CCC(NC4CCOCC4)CC3)c(-c3nc(C)no3)c(C)c2c1","inchiKey":"CQOJHAJWCDJEAT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BTRX-335140","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BTRX-335140","Btrx-335140","CYM-53093"],"childChemblIds":["CHEMBL4455146"],"linkedTargets":{"rows":["ENSG00000082556"],"count":1},"linkedDiseases":{"rows":["MONDO_0002009"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594261","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H]([18F])[C@@H]2O","inchiKey":"KDLLNMRYZGUVMA-ZYMZXAKXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUOROESTRADIOL F-18","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1627367","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cerianna"],"synonyms":["(18f)-fes","16.alpha.-(18f)fluoroestradiol","F-18 16 alpha-fluoroestradiol","F-18 16-alpha-fluoroestradiol","F-18 fes","Fes f-18","Fluoroestradiol (18f)","Fluoroestradiol f-18","Fluoroestradiol f18","NSC-743445"],"crossReferences":{"DailyMed":["fluoroestradiol%20f-18"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for breast cancer."}
{"id":"CHEMBL4594581","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN 287","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Insulin 287","Insulin icodec","Long-acting-insulin-287","NNC0148-0287","Nnc0148-0287"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL46469","canonicalSmiles":"O=C1c2c(O)cccc2Cc2cccc(O)c21","inchiKey":"NUZWLKWWNNJHPT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTHRALIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alphodith","Anthra-derm","Antraderm","Dithrocream","Dithrocream fte","Dithrocream hp","Drithocreme","Drithoscalp","Lasan","Micanol","Psoradrate","Psorin","Psorin fte","Stie-lasan"],"synonyms":["Anthraderm","Anthralin","Batidrol","Batridol","Chrysodermol","Cignolin","Cigthranol","Derobin","Dithranol","NSC-43970","NSC-629313","Psodadrate","Psoriacid-stift","Psoriacide"],"crossReferences":{"PubChem":["144204666","144209049","144210610","170466655","17389175","26747336","57260153","98251"],"Wikipedia":["Dithranol"],"drugbank":["DB11157"],"chEBI":["37510"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for psoriasis."}
{"id":"CHEMBL4650282","canonicalSmiles":"CC(C)(C)N.Cc1cn(C(=O)c2c(-c3c(Cl)cc(Cl)cc3Cl)noc2C(C)(C)F)c2cccc(/C=C/C(=O)O)c12","inchiKey":"UPPAAWQBZQBNIE-USRGLUTNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DS-1001B","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4651002","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DS-1001b","Ds-1001b"],"linkedTargets":{"rows":["ENSG00000138413"],"count":1},"linkedDiseases":{"rows":["MONDO_0021639"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL4650295","drugType":"Cell","blackBoxWarning":false,"name":"AMG553","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG553","Amg 553","Amg553"],"linkedTargets":{"rows":["ENSG00000122025"],"count":1},"linkedDiseases":{"rows":["EFO_0000222"],"count":1},"description":"Cell drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650349","canonicalSmiles":"O=C(c1ccc(F)cc1)c1ccccc1N[C@@H](Cc1ccc(OCCn2c3ccccc3c3ccccc32)cc1)C(=O)O","inchiKey":"QNLWMPLUWMWDMQ-YTTGMZPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHIGLITAZAR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS 038","CS-038","Carfloglitazar, (s)-","Chiglitazar"],"linkedTargets":{"rows":["ENSG00000112033","ENSG00000186951","ENSG00000132170"],"count":3},"linkedDiseases":{"rows":["EFO_1001249","MONDO_0005148"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4650402","drugType":"Unknown","blackBoxWarning":false,"name":"JNJ-63733657","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Jnj-63733657"],"linkedTargets":{"rows":["ENSG00000186868"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4802197","drugType":"Unknown","blackBoxWarning":false,"name":"INOBRODIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CCS-1477","CCS1477","Ccs1477","Inobrodib"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802207","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-1795091","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CRX-601","GSK-1795091","GSK1795091","Gsk-1795091","Gsk1795091"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL485835","canonicalSmiles":"C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(CCOCc3cc(F)cc(F)c3)[C@@H](O)CC[C@@H]12","inchiKey":"AJODXHGZHBERGJ-JLYQOUBASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL485835","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07717"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489","canonicalSmiles":"CC/C(=C(\\c1ccc(O)cc1)c1ccc(OCCN(C)C)cc1)c1ccccc1","inchiKey":"TXUZVZSFRXZGTL-QPLCGJKRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AFIMOXIFENE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Tamogel"],"synonyms":["4-Hydroxytamoxifen","4-OHT","Afimoxifene"],"crossReferences":{"PubChem":["11532960","144208141","26757818","56422185"],"Wikipedia":["Afimoxifene"],"drugbank":["DB04468"],"chEBI":["44616"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009","ENSG00000196482"],"count":3},"linkedDiseases":{"rows":["EFO_1001366","EFO_0000432"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL507674","canonicalSmiles":"CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)C(=O)C1=O","inchiKey":"GCFBRXLSHGKWDP-XCGNWRKASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFOPERAZONE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefoperazone","Peracef"],"crossReferences":{"Wikipedia":["Cefoperazone"],"drugbank":["DB01329"],"chEBI":["3493"]},"childChemblIds":["CHEMBL1551899","CHEMBL1200482","CHEMBL1697715"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL55483","canonicalSmiles":"Cc1cc(CCCCCCCOc2ccc(C3=N[C@H](C)CO3)cc2)on1","inchiKey":"NEAZMARKCJKUMF-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL55483","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL571948","canonicalSmiles":"C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1","inchiKey":"JTVBXQAYBIJXRP-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Y-39983","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Y-39983"],"childChemblIds":["CHEMBL3794409"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL681","canonicalSmiles":"CCOC(=O)c1cncn1[C@H](C)c1ccccc1","inchiKey":"NPUKDXXFDDZOKR-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOMIDATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amidate","Etomidate"],"synonyms":["Etomidate","Hypnomidate","NSC-759160"],"crossReferences":{"DailyMed":["etomidate"],"PubChem":["11114097"],"drugbank":["DB00292"],"chEBI":["4910"]},"linkedTargets":{"rows":["ENSG00000109158","ENSG00000145863","ENSG00000011677","ENSG00000187730","ENSG00000151834","ENSG00000145864","ENSG00000166206","ENSG00000182256","ENSG00000022355","ENSG00000102287","ENSG00000094755","ENSG00000268089","ENSG00000113327","ENSG00000163285","ENSG00000186297","ENSG00000163288"],"count":16},"linkedDiseases":{"rows":["EFO_0009686","MONDO_0002050","MONDO_0001208","EFO_0005323","EFO_0000712","EFO_0001645","EFO_1001905","HP_0001336","EFO_0009267","EFO_0000537"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 investigational indications."}
{"id":"CHEMBL780","canonicalSmiles":"O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O","inchiKey":"QPCDCPDFJACHGM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PENTETIC ACID","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["DTP-A","DTPA","NSC-7340","Pentetate","Pentetic acid"],"crossReferences":{"DailyMed":["pentetate%20calcium%20trisodium","pentetate%20zinc%20trisodium"],"PubChem":["104171146","11111089","11111090","144203682","170465150","26753562","50106210","85231007","90341568"],"Wikipedia":["Pentetic_acid"],"drugbank":["DB14007"],"chEBI":["35739"]},"childChemblIds":["CHEMBL1200424","CHEMBL1200945"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for pulmonary embolism and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL90555","canonicalSmiles":"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"OGWKCGZFUXNPDA-XQKSVPLYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VINCRISTINE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["22-oxovincaleukoblastine","Leucristine","Leurocristine","Oncotcs","Tecnocris","Vincaleukoblastine, 22-oxo-","Vincristin","Vincristine","Vinkristin"],"crossReferences":{"PubChem":["124892473","144205620","170465186"],"chEBI":["28445"]},"childChemblIds":["CHEMBL501867"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0004708","EFO_0000637","EFO_0000558","EFO_0000756","EFO_1000131","EFO_0005952","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0007160","MONDO_0015760","EFO_1000318","EFO_1001935","EFO_0000588","EFO_0000096","MONDO_0002974","HP_0001871","MONDO_0019088","MONDO_0008903","MONDO_0015540","EFO_0002918","MONDO_0003540","EFO_0000094","Orphanet_654","EFO_0009441","EFO_0000198","EFO_1000292","EFO_0000220","MONDO_0018271","EFO_0000248","EFO_0000180","EFO_0002939","Orphanet_636","EFO_0000502","EFO_1001946","MONDO_0044881","EFO_0009708","EFO_1001365","MONDO_0044889","EFO_0003032","EFO_0009254","MONDO_0044917","EFO_0000574","EFO_0001378","MONDO_0015564","MONDO_0009348","MONDO_0000432","MONDO_0019471","EFO_0000255","Orphanet_790","MONDO_0016236","EFO_1001469","EFO_0000209","MONDO_0004095","MONDO_0003541","MONDO_0016700","EFO_0000272","EFO_0004289","EFO_1001830","MONDO_0001657","EFO_0002499","EFO_0000183","MONDO_0020743","EFO_0010580","MONDO_0002083","MONDO_0002618","EFO_1000635","MONDO_0003478","EFO_1000158","MONDO_0000430","EFO_0000616","EFO_0006859","EFO_1000616","EFO_0000765","EFO_0000437","Orphanet_59305","EFO_0000403","Orphanet_1063","EFO_1001042","MONDO_0000870","EFO_0000222","EFO_0000313","MONDO_0016717","EFO_0000621","EFO_0000311","EFO_0000211","EFO_0000095","EFO_0005235","EFO_0000174","EFO_1001936","EFO_1002008","EFO_1001947","MONDO_0002367","EFO_0000702","MONDO_0018906","MONDO_0019004","EFO_0003833","EFO_0000691","EFO_0000519","MONDO_0021637"],"count":101},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and is indicated for neoplasm and has 86 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL914","canonicalSmiles":"CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1","inchiKey":"RWTNPBWLLIMQHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEXOFENADINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Allegra","Fexofenadine"],"crossReferences":{"DailyMed":["fexofenadine%20hydrochloride"],"PubChem":["50105687","90341422"],"Wikipedia":["Fexofenadine"],"drugbank":["DB00950"],"chEBI":["5050"]},"childChemblIds":["CHEMBL1200618"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000685","EFO_0008521","HP_0000989","EFO_0000401","EFO_0009373","MONDO_0005271","EFO_0000274","EFO_0003060","EFO_0003948","EFO_0005531","EFO_0004253","MONDO_0004979","EFO_1001417","EFO_0003956"],"count":15},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 4 approved and 9 investigational indications."}
